Leaflet MST CONTINUS 200mg modified-release film-coated tablets
Indicated for: moderate to severe pain
Route of administration: oral
Substance: morphine (opioid analgesic)
ATC: N02AA01 (Nervous system | Opioids | Natural opium alkaloids)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may cause dependence or be misused.
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol during treatment.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
Morphine is a powerful opioid analgesic used to treat moderate to severe pain, particularly in cases of chronic pain associated with cancer, postoperative pain, or other serious conditions. It works by binding to opioid receptors in the central nervous system, reducing the perception of pain and the emotional response to it.
Morphine is available in various forms, including tablets, capsules, oral solutions, injections, and transdermal patches. The dosage and form of administration are determined by the doctor based on the severity of the pain and the patient’s condition.
Common side effects include drowsiness, constipation, nausea, vomiting, dizziness, and dry mouth. Long-term use can lead to the development of tolerance (requiring higher doses for the same effect) and physical or psychological dependence. In severe cases, overdose can cause respiratory depression, which may be fatal.
Morphine is contraindicated in patients with severe respiratory insufficiency, intestinal obstruction, or hypersensitivity to opioids. Its use during pregnancy or breastfeeding should be done with caution, as it may affect the fetus or infant. It is essential that morphine is used strictly according to the medical prescription, and patients should be monitored for signs of abuse or dependence.
General data about MST CONTINUS 200mg
- Substance: morphine
- Date of last drug list: 01-07-2013
- Commercial code: W44126001
- Concentration: 200mg
- Pharmaceutical form: modified-release film-coated tablets
- Quantity: 60
- Product type: original
- Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.
Pharmaceutical forms available for morphine
Concentrations available for morphine
- 100mg
- 10mg
- 200mg
- 20mg
- 20mg/ml
- 30mg
- 60mg